Portfolio overview

As at 31 August 2026

10 largest holdings

(% of total investments)

Name

Total

Vertex Pharmaceuticals

3.4

C4 Therapeutics

4.0

Travere Therapeutics

3.0

Vogenx

Biogen

2.8

uniQure

2.7

Palvella Therapeutics

2.8

Arcutis Biotherapeutics

3.3

Edgewise Therapeutics

2.3

Rhythm Pharmaceuticals

2.3

Total

28.7

Geographic breakdown

(%)

  • North America 86% 86
  • Continental Europe 8.9% 8.9
  • China 3.8% 3.8
  • United Kingdom 0.6% 0.6
  • Taiwan 0.5% 0.5
  • Unquoted ‡ 0.2% 0.2

Return vs volatility

(Annualised since appointment of OrbiMed: May 2005) – Chart (%)

Plot graph showing return vs volatility of Finsbury Growth & Income Trust (price) and FTSE All-Share Index (total return)